Profil
John Barrie Ward is currently a Director at ADC Products (UK) Ltd. and ADC Therapeutics (UK) Ltd. He previously held positions as Chairman & Chief Executive Officer at Virus Research Institute, Inc., Chief Executive Officer at KuDOS Pharmaceuticals Ltd., Chairman at CellCentric Ltd. (2012-2013), Chairman at ImmunoBiology Ltd., Non-Executive Chairman at London Genetics Ltd., Director at AVANT Immunotherapeutics, Inc., Non-Executive Director at Biotica Technology Ltd., Independent Non-Executive Director at Pharming Group NV (2007-2021), Director at Cancer Research Technology Ltd., Studies Director & Member-Microbiology Division at The National Institute For Medical Research, Non-Executive Director at BerGenBio ASA, Director-Microbiology Division at Glaxo Research Laboratories (1984-1994), Non-Executive Director at ADC Therapeutics SA, Director at Spirogen SARL, and Principal at AstraZeneca AB. He obtained undergraduate and doctorate degrees from the University of Bath.
Postes actifs de John Barrie Ward
| Sociétés | Poste | Début |
|---|---|---|
ADC Products (UK) Ltd.
ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services Develops therapeutic technologies for cancer and infectious diseases treatment | Directeur/Membre du Conseil | 23/06/2016 |
ADC Therapeutics (UK) Ltd.
ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Provides research and experimental development in biotechnology | Directeur/Membre du Conseil | 12/03/2015 |
Anciens postes connus de John Barrie Ward
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMING GROUP N.V. | Directeur/Membre du Conseil | 19/05/2021 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Directeur/Membre du Conseil | 16/04/2007 |
KuDOS Pharmaceuticals Ltd.
KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products | Directeur Général | 01/01/2006 |
Virus Research Institute, Inc.
Virus Research Institute, Inc. BiotechnologyHealth Technology Develops systems for the delivery of vaccines | Directeur Général | - |
Glaxo Research Laboratories | Corporate Officer/Principal | - |
Formation de John Barrie Ward
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Virus Research Institute, Inc.
Virus Research Institute, Inc. BiotechnologyHealth Technology Develops systems for the delivery of vaccines | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Biotica Technology Ltd.
Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
KuDOS Pharmaceuticals Ltd.
KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products | Health Technology |
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Develops cancer therapeutics, vaccines, and diagnostics | Health Technology |
The National Institute For Medical Research
The National Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule inhibitors for cancer | Health Technology |
ImmunoBiology Ltd.
ImmunoBiology Ltd. BiotechnologyHealth Technology Develops next generation anti-infective vaccines | Health Technology |
ADC Products (UK) Ltd.
ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services Develops therapeutic technologies for cancer and infectious diseases treatment | Health Services |
London Genetics Ltd. | |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Glaxo Research Laboratories | |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Spirogen SARL
Spirogen SARL Miscellaneous Commercial ServicesCommercial Services Operates as an oncology-focused biotechnology company | Commercial Services |
ADC Therapeutics (UK) Ltd.
ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Provides research and experimental development in biotechnology | Health Technology |
















